On December 18, a petition was filed with the FDA by the Physicians Committee for Responsible Medicine. It asks the FDA to require that diabetic medications in the thiazolidinedione class of drugs like Avandia include labeling that states a low-fat vegan diet has been shown to be as effective or more effective than medications taken […]
Physicians who use complementary and alternative therapies in their clinical practices often face charges from their respective state boards of medicines for practicing “outside the standard of care.” USA Today has conducted a review of the state pharmacy board panels, who are assigned to oversee prescription drug safety for American consumers. They found that nearly […]
Freedom of healthcare choice has long been an issue when dealing with government-funded healthcare plans like Medicare and Medicaid. For instance, the Watson-Burton legislation attempted to address economically disadvantaged persons who rely on Medicaid for health insurance because they were given no dental freedom of choice. For most families on Medicaid, the choice is either […]
The Promotional Products Association International is a trade group of very unhappy companies facing a severe downturn in business. These companies provide the promotional products which drug makers use to influence physician prescribing habits.
An inflammatory article appeared last week in the Wall Street Journal called “The Touch that Doesn’t Heal .” It deserves a thorough reading and some impassioned letters to the editor. The article, written by Steve Salerno, claims that “Americans pay billions for alternative medicine—with nothing to show for it.”
Researchers from NIH’s Women’s Health Initiative released a study this December tying the use of synthetic prescription hormones to breast cancer.
In July 2005, the FDA banned the use of an animal antibiotic called Baytril, citing a threat to human health.
The Wall Street Journal recently published an article entitled “What You Don’t Know About a Drug Can Hurt You.”
Sen. Charles Grassley (R-IA), a member of the Senate Finance Committee, has repeatedly made the news with his ongoing investigation into drug industry influence on doctors.